Dr Andrew Kompa
Honorary Senior Fellow
Department of Medicine
188 Scholarly works
14 Projects
HIGHLIGHTS
2026
Journal article
Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury
DOI: 10.1186/s13287-025-04847-92026
Journal article
Innovative cell therapy with sustained mesenchymal stem cell secretome for long-term cardioprotection
DOI: 10.1016/j.jmccpl.2025.1005232026
Journal article
Understanding The Dose Response Effects of PI3K on Atrial Fibrosis and Factors Released from The Heart
DOI: 10.1016/j.jmccpl.2025.1006232025
Journal article
PI3K(p110a) regulates atrial function independent of fibrosis and is a critical regulator of atrial enlargement in a setting of pressure overload-Implications for atrial myopathy & atrial fibrillation
DOI: 10.1093/eurheartj/ehaf784.47482022
Research Contracts
OCX Project - PC-24
2018
Research Contracts
Analysis of FT011 Phase 1 Urine Samples
2018
Research Grant
Adenosine Receptor Context-Specific Biased Agonism to Treat Ischaemic Heart Disease
RECENT SCHOLARLY WORKS
2025
Journal article
An optimized plasmalogen modulating dietary supplement provides greater protection in a male than female mouse model of dilated cardiomyopathy
DOI: 10.1016/j.jmccpl.2024.1002732024
Journal article
Targeting G protein-coupled receptors for heart failure treatment
DOI: 10.1111/bph.160992024
Book Chapter
Rat Models of Cardiorenal Syndrome and Methods for Functional Assessment
DOI: 10.1007/978-1-0716-3846-0_112023
Journal article
WCN23-1158 A TRANSLATIONAL APPROACH TO IDENTIFY NON-INVASIVE SURROGATES AS PREDICTORS OF RESPONSE TO mFT011 IN KIDNEY DISEASE
DOI: 10.1016/j.ekir.2023.02.5182022
Journal article
Identification of Noninvasive Surrogates as Predictors of Response to FT011 in Kidney Disease
DOI: 10.1681/asn.20223311s1164b2022
Journal article
Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings
DOI: 10.3390/toxins14020100
RECENT PROJECTS
2024
Research Contracts
Certa Therapeutics 2024-Ct-Pc-23
2022
Research Contracts
Effect of Novel Agents in the STNx Model of Chronic Kidney Disease